EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

Trailblazing VIARES changes the standards for entry-level CRAs

VIARES is the first independent organization to achieve IAOCR 5 star accreditation for their industry-newcomers training course Maidenhead, United Kingdom and Vienna...
Continue Reading →
Europe

CRF Health Launches Self-Service Model for TrialConsent® Platform

Self-service Version Enables Sponsors and CROs to Take Control of eConsent Technology Plymouth Meeting, PA – 20 August 2018: CRF Health, the leading global provider o...
Continue Reading →
Europe

Benzodiazepines are associated with increased risk of Alzheimer’s disease

The use of benzodiazepines and related drugs (Z drugs) is associated with a modestly increased risk of Alzheimer’s disease, according to a recent study from the Univ...
Continue Reading →
news

New technique treats prostate cancer in just five radiotherapy sessions

A new clinical trial shows the benefits of an innovative form of radiation therapy, which delivers the radiation in only five sessions instead of the usual 37. A n...
Continue Reading →
news

Endometriosis drug approved by the FDA to reduce pain

A new drug is shown to ease three different types of endometrios Endometriosis is a condition affecting around 1 in 10 women in the United States, and around 200 mill...
Continue Reading →
Europe

Europe’s first allogeneic stem cell therapy rejected by NICE

Cost regulators for the NHS in England and Wales have not approved funding for TiGenix and Takeda’s Alofisel - the first allogeneic stem cell therapy to be approved ...
Continue Reading →
news

FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease

The U.S. Food and Drug Administration approved Onpattro (patisiran) infusion for the treatment of peripheral nerve disease (polyneuropathy) caused by hereditary tran...
Continue Reading →
news

Oxford Genetics signs major supply and licensing agreement for CRISPR engineered mammalian cell lines

Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has secured a multi-million pound cont...
Continue Reading →
news

Quanticate Names David Hukin Senior Director of Pharmacovigilance

London, UK, Quanticate, a leading global data-focused clinical research organisation (CRO) has named David Hukin as the company's new Senior Director of Pharmacovigil...
Continue Reading →
news

Cellect Granted Key European Patent for Its Stem Cell Selection Technology

Through negative selection, Cellect's technology identifies mature cells that can be harmful to the recipient and selectively eliminates those cells through apoptosis...
Continue Reading →
Quotient